v3.26.1
Restructuring and Related Costs - Summary of Restructuring and Related Costs (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Restructuring Costs and Asset Impairment Charges [Abstract]        
Clinical trial expense and other third-party costs for the deprioritization of the luvelta program $ 201 $ 13,006 $ 243 $ 17,261
Severance and benefits expense 0 3,862 0 12,372
Contract termination and other restructuring costs 0 1,554 0 9,832
Total $ 201 $ 18,422 $ 243 $ 39,465